fashion -WSS

fashion

author：explore 2025-09-29 01:46:21 - browse：45

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the third quarter:

Novo Nordiskis conducting a large clinical trial to prove that its GLP-1 drug Wegovy, in addition to helping people lose weight, also improves cardiovascular health. The SELECT study enrolled 17,500 participants who had overweight or obesity and had preexisting heart disease. The participants were then randomized to receive weekly injections of Wegovy or a matching placebo. The primary goal is to determine the extent to which Wegovy reduces the risk of heart attacks, strokes, and heart-related deaths. Wegovy is already a blockbuster drug based on weight loss alone, but proving an additional cardiovascular benefit could open the commercial floodgates.

BridgeBiowill report in July an analysis of all-cause mortality from a clinical trial of its heart drug acoramidis. The outcome is an important, second attempt at demonstrating benefit for acoramidis in a progressive heart disease called ATTR-CM. In December 2021, the drug performed no better than a placebo on a test of how far study participants could walk over the course of six minutes, failing to achieve its primary goal. But in this second part of the same study, BridgeBio will determine if acoramidis can significantly reduce hospitalizations and death over the course of 30 months.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The high cost of giving birth even with insurance
Next article： Use wet bulb globe temperature, not heat index, to protect workers

WSS

Behind warning on Apellis’s eye drug lies a conflict of interest

Readout LOUD podcast: brain research, obesity drug sales, Novartis

Public health communication lessons from Covid

How to improve immunocompromised access to mAb treatments

Biden announces an advanced cancer research initiative

CDC wastewater surveillance dashboard to track bird flu hotspots

hotspot

fashion

entertainment

Alkermes shareholders re

Biden announces an advanced cancer research initiative

Walensky prepares to leave CDC — and Congress — behind

‘We were in the air.’ Mississippi family recounts surviving tornado that tore mobile home apart

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

VC firm RA Capital starts a new synthetic biology incubator

Bright Health sells Medicare Advantage business to Molina

First recipient of genetically engineered pig kidney has died

Psychedelics group wrestles with new pharma identity

The mammogram wars are not over

knowledge

Making AI in medicine accessible to smaller, and rural hospitals

The mammogram wars are not over

American Airlines has a tentative contract deal with its pilots. Southwest is still negotiating

VC firm RA Capital starts a new synthetic biology incubator

Timeline: Special counsel's probe into Trump's handling of classified documents

McConnell had minor fall 2 weeks ago, uses wheelchair periodically to get around: Sources

entertainment

explore

focus

hotspot